| Acceptance No. | Drug Name | Active Ingredient | Dosage Form | Classification | Submission | Acceptance Date | Manufacturers | Manufacturers | Review Status | Status Date | View |
|---|---|---|---|---|---|---|---|---|---|---|---|
| CXSL1800023 | 重组抗VEGFR2全人源单克隆抗体（JY025）注射液 | Recombinant anti-VEGFR2 human monoclonal antibody | Injection | Biological Products(1) | New Drug Application | 2018-03-05 | 北京东方百泰生物科技有限公司 | Beijing Dongfang Biotech Co Ltd | Certificate Issued | 2018-07-24 | view |